First-in-human evaluation of (18)F-PF-06445974, a PET radioligand that preferentially labels phosphodiesterase-4B. Wakabayashi Y, Strenkona P, Arakawa R, Yan X, et al. J Nucl Med 2022 Jun 30. pii: jnumed.122.263838. doi: 10.2967/jnumed.122.263838.

Read + Share

Amedeo Smart

Independent Medical Education

Wakabayashi Y, Strenkona P, Arakawa R, Yan X, et al. First-in-human evaluation of (18)F-PF-06445974, a PET radioligand that preferentially labels phosphodiesterase-4B. J Nucl Med 2022 Jun 30. pii: jnumed.122.263838. doi: 10.2967/jnumed.122.263838.
PMID: 35772961